Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microtubule-associated protein tau (MAPT) is a critical component of the neuronal cytoskeleton, primarily responsible for stabilizing microtubules in axons (UniProt: P10636). The microtubule-binding region (MTBR) of tau contains three or four highly conserved repeats, each ending with a characteristic HVPGG motif or its variants. This motif plays a dual role: it facilitates the binding of tau to microtubules under physiological conditions and serves as a nucleation site for the formation of pathological tau aggregates in neurodegenerative diseases (von Bergen et al., 2000). In tauopathies such as Alzheimer's disease, the HVPGG motif undergoes conformational changes that promote the assembly of tau into paired helical filaments (PHFs) and neurofibrillary tangles (Wischik et al., 2014). Therapeutic strategies targeting this motif aim to inhibit the aggregation process or promote the disassembly of existing aggregates. Small molecules like hydromethylthionine mesylate (LMTM) have been designed to interact with the MTBR to prevent the pathological transition of tau (Gerson et al., 2014). Understanding the structural dynamics of the HVPGG motif is essential for developing effective disease-modifying treatments for tau-mediated neurodegeneration.
Inhibition of tau-tau interaction and dissolution of paired helical filaments (PHFs) by binding to the repeat domain and preventing beta-sheet formation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule-associated protein tau (MAPT) microtubule-binding region HVPGG motif (Tau MTBR HVPGG).